Regentis Biomaterials (RGNT) Liabilities and Shareholders Equity (2024 - 2025)
Regentis Biomaterials' (RGNT) quarterly Liabilities and Shareholders Equity came in at $7.6 million in Q4 2025, up 1480.5% year-on-year from $482000.0 in Q4 2024, and up 1480.5% on a QoQ basis from $482000.0 in Q4 2024.
Regentis Biomaterials (RGNT) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has 2 years of Liabilities and Shareholders Equity data on file, last reported at $7.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 31.62 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 50.83 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 39.01 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 8.78 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 14.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.31 Bn |
| 10 | Regentis Biomaterials | 1.10 Mn | -6.28 Mn | - | 7.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.62 Mn |
| Dec 31, 2024 | 482,000.00 |